Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2001
06/13/2001EP1105493A1 Basb024 outer membrane protein of neisseria meningitidis
06/13/2001EP1105492A1 Cloning of basb023 antigen from moraxella catarrhalis
06/13/2001EP1105491A1 Expression of bacterial signal molecules in plants
06/13/2001EP1105490A1 Nucleic acid molecules encoding inclusion membrane protein c of chlamydia
06/13/2001EP1105489A1 Nucleic acid molecules encoding pomp91a protein of chlamydia
06/13/2001EP1105488A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
06/13/2001EP1105487A1 Recombinant multivalent malarial vaccine against plasmodium falciparum
06/13/2001EP1105485A1 Human il-1 epsilon dna and polypeptides
06/13/2001EP1105484A1 Antithrombin nucleotides and proteins from horn fly
06/13/2001EP1105483A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses
06/13/2001EP1105482A2 Genes that regulate hematopoietic blood forming stem cells and uses thereof
06/13/2001EP1105481A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
06/13/2001EP1105480A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family
06/13/2001EP1105479A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
06/13/2001EP1105478A1 Extracellular adhesive proteins, exadh1 and exadh2
06/13/2001EP1105477A1 Dcr5, a bmp-binding protein, and applications thereof
06/13/2001EP1105476A1 Pharmaceutical composition for treating or preventing diabetes or cancer, or the waardenburg syndrome
06/13/2001EP1105475A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia
06/13/2001EP1105474A2 Human genes and gene expression products v
06/13/2001EP1105473A2 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof
06/13/2001EP1105470A1 USE OF SUPPRESSOR tRNA'S TO REGULATE CYTOTOXICITY DURING THE PRODUCTION OF RECOMBINANT GENE PRODUCTS
06/13/2001EP1105466A1 Process for purifying human papillomavirus virus-like particles
06/13/2001EP1105465A1 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE
06/13/2001EP1105461A2 Methods of forming neurons
06/13/2001EP1105460A2 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof
06/13/2001EP1105428A1 Novel cleaved fragments of fibrinogen
06/13/2001EP1105424A1 Method for producing a balanced antibody composition and for purifying constituents of biological liquids
06/13/2001EP1105423A1 A mutant of tissue factor pathway inhibitor, dna sequence and use for detecting thrombotic disorders
06/13/2001EP1105422A1 Hepatitis c inhibitor peptides
06/13/2001EP1105421A2 Anti-inflammatory peptides derived from il-2 and analogues thereof
06/13/2001EP1105420A1 Cyclic prosaposin-derived peptides and uses thereof
06/13/2001EP1105419A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
06/13/2001EP1105418A1 Vanadate resistance glycosylation 4 gene
06/13/2001EP1105417A1 Nucleic acid and polypeptide p10 of a borna disease virus (bdv) and their use for diagnostic and immunization purposes
06/13/2001EP1105414A2 Synthetic peptides and methods of use for autoimmune disease therapies
06/13/2001EP1105411A1 nrdE
06/13/2001EP1105410A1 Purification of blood clotting proteins
06/13/2001EP1105409A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
06/13/2001EP1105406A1 Novel esk potassium channel polypeptide and polynucleotide compositions
06/13/2001EP1105405A2 Gene regulating circadian clock function and photoperiodism
06/13/2001EP1105160A1 Lats knock-out animal models and their uses
06/13/2001EP1105158A1 Synthetic peptide immunogens and antibodies thereto
06/13/2001EP1105157A1 Protein delivery system using human papillomavirus virus-like particles
06/13/2001EP1105156A1 Non-virulent porphyromonas gingivalis mutant
06/13/2001EP1105154A1 Bacterial superantigen vaccines
06/13/2001EP1105153A1 Multivalent vaccine for (clostridium botulinum) neurotoxin
06/13/2001EP1105152A1 Tnf-derived peptides for use in treating oedema
06/13/2001EP1105142A2 Blood-brain barrier therapeutics
06/13/2001EP1105051A1 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
06/13/2001EP0837873A4 Novel enhancer sequences for late t cell expressed genes
06/13/2001EP0789776B1 Nucleic acid transfer system
06/13/2001EP0675728B1 Products and methods for improving keratinocyte adhesion to the dermis
06/13/2001EP0656010B1 Use of peptides causing a immune response for the preparation of medicaments to induce the suppression of the immune reaction.
06/13/2001EP0651765B1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis
06/13/2001EP0580649B1 Plant promoter involved in controlling lipid biosynthesis in seeds
06/13/2001DE19963690A1 Vektoren und Verfahren zur Herstellung rekombinanter Proteine in Pilzen Vectors and methods for producing recombinant proteins in fungi
06/13/2001DE19959934A1 New heparin-binding proteins from glial cells, useful for treating injuries to the central nervous system, induce regeneration of synaptic connections
06/13/2001DE19959582A1 Nukleinsäuren, die für neue Acetylcholinrezeptor-beta-Untereinheiten von Insekten kodieren Nucleic acids coding for new acetylcholine receptor beta subunits of insect
06/13/2001DE19959328A1 Neue für das zwa1-Gen codierende Nukleotidsequenzen New coding for the zwa1 gene nucleotide sequences
06/13/2001DE19959327A1 Neue für das zwa2-Gen codierende Nukleotidsequenzen New coding for the zwa2 gene nucleotide sequences
06/13/2001DE19958680A1 cDNA-Sequenzen von zwei Interaktoren FANCIP4 und FANCIP5 der Fanconi-Anämie-Pr oteine der Komplementationsgruppen A und C cDNA sequences of two interactors FANCIP4 and FANCIP5 the Fanconi anemia-Pr oteine ​​the complementation groups A and C
06/13/2001DE19957838A1 Gentherapie von HIV-Infizierten durch Expression von Membran-verankerten gp41-Peptiden Gene therapy of HIV-infected individuals by expression of membrane-anchored gp41 peptides
06/13/2001DE19957689A1 Proteaseresistenter Tumorsuppressor p14(ARF) Protease-resistant tumor suppressor p14 (ARF)
06/13/2001DE19956763A1 Reducing interaction of adenoviral vectors with blood cells, useful for ex vivo gene therapy, by mutating the fiber-encoding gene in vectors or helper constructs, reduces toxicity
06/13/2001CN1299418A Renicillin binding protein gene and process for producing L-glutamic acid
06/13/2001CN1299417A Chimeric proteins with cell-targeting specificity and apoptosis-dinducing activities
06/13/2001CN1299414A Compound and method for therapy and diagnosis of lung cancer
06/13/2001CN1299411A Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
06/13/2001CN1299407A Vascular endothelial growth factor 2
06/13/2001CN1299369A Plasminogen-related gene B polypeptides
06/13/2001CN1299288A Combined vaccine compositions
06/13/2001CN1299287A Vaccines comprising interleukin-12 and herpes simplex viral antigen
06/13/2001CN1298884A Human cyclic adenylicacid dependent protein kinase inhibitor-9 and polynucleotide for coding said polypeptide
06/13/2001CN1298883A Preparing process and application of recombined human interleukin-11
06/13/2001CN1298882A Human Na-dependent phosphate cotransporter 35 and its coding sequence
06/13/2001CN1298881A Solid, stable and concentrated type ortho-silicis acid complex based on bio-absorption, and its prepn. method
06/13/2001CN1067104C Method for prepn. of secretion of hirudin derivatives
06/12/2001US6245970 A dna molecule that when introduced into a plant genome modifies the transfer of metabolites in transgenic plants, plasmids, bacteria and yeast
06/12/2001US6245969 A polypeptide for producing genetically engineered plants having a phenotype of increased crop yield, enhanced disease resistance and longer-lived vegetative growth phase
06/12/2001US6245966 Adenoviral mediated gene transfer into lymphocytes
06/12/2001US6245965 Knockout mice and cells that lack p19INK4d and p27KIP1 activity and methods of use thereof
06/12/2001US6245964 A non-human animal that is homozygous for the diploid genome encoding a polypetide with a swedish mutation at position 595 with amino acid residues being aspargine and leucine; this mutation is detectable in brain homogenate
06/12/2001US6245963 Knockout-transgenic mouse model of spinal muscular atrophy
06/12/2001US6245906 Probes for the diagnosis of infections caused by Streptococcus pyogenes
06/12/2001US6245905 A nucleic acid molecule; generate transgenic plants that are tolerant to multiple environmental stresses
06/12/2001US6245904 Recombinant polypeptide based on the primary sequence of the invariant chain with at least one primary sequence of a specific T-cell epitope or a protein derivative and nucleic acids coding for this recombinant polypeptide
06/12/2001US6245901 Modified polypeptide
06/12/2001US6245900 Polypeptide wherein at least one of the amino, carboxyl, mercapto or guanidino groups in a polypeptide molecule having human granulocyte colony stimulating factor activity is chemically modified by a maleic acid styrene polymer
06/12/2001US6245899 Composition for detection of cell density signal molecule
06/12/2001US6245898 Antibodies that inhibit tumor metastasis; diagnosis and therapy of metastic cancers
06/12/2001US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization
06/12/2001US6245895 Antigen/antibody specificity exchanger
06/12/2001US6245893 Receptor that binds anti-convulsant compounds
06/12/2001US6245891 nusB polypeptides and polynucleotides and methods thereof
06/12/2001US6245890 A purified red blood cell antigen which binds to zenoreactive human antibodies; therapy for xenograft rejection
06/12/2001US6245889 BMP-4 products
06/12/2001US6245888 Proteins involved in the regulation of cell—cell adhesion and uses thereof
06/12/2001US6245886 Peptides and peptidomimetics with structural similarity to human P53 that activate P53 function
06/12/2001US6245885 Bax-mediated apoptosis modulating reagents and methods
06/12/2001US6245883 An isolated lectin derived peptide; therapy, antiinflammatory agent, suppressing cell adhesion, antimetastasis agents